Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04218201 · ClinicalTrials.gov registry record · NA
Subthreshold Opioid Use Disorder Prevention (STOP) Trial
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 321
- Enrollment target
NCT04218201 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 321 participants.
The verdict
NCT04218201, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 321 participants
- Enrollment target
Study Summary
The Subthreshold Opioid Use Disorder Prevention (STOP) trial will test the efficacy of a primary care intervention to reduce opioid use and overdose risk, and prevent progression to OUD, in adults with unhealthy use of illicit or prescribed opioids. STOP is a collaborative care model. A cluster-randomized trial, conducted in 5 primary care sites, with 100 PCPs and 300adult primary care patients, will test the efficacy of STOP versus enhanced usual care (EUC). The STOP intervention, if proven efficacious, will provide a solution to preventing OUD among patients who are most at risk, thus addressing a key aspect of the current opioid crisis.
Interventions
- BEHAVIORAL PCP brief advice
- BEHAVIORAL Video doctor
- BEHAVIORAL Telephone health coaching
- BEHAVIORAL Nurse Care Manager (NCM) intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 321 participants |
| Start Date | 2020-03-25 |
| Est. Completion | 2024-05-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04218201
The ClinicalTrials.gov registry entry for NCT04218201 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 321 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which PCP brief advice is the first listed.
NCT04218201 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04218201 about?
NCT04218201 is a clinical study titled "Subthreshold Opioid Use Disorder Prevention (STOP) Trial". The Subthreshold Opioid Use Disorder Prevention (STOP) trial will test the efficacy of a primary care intervention to reduce opioid use and overdose risk, and prevent progression to OUD, in adults with unhealthy use of illicit or prescribed opioids. STOP is a collaborative care model. A cluster-rand...
What is the current status of trial NCT04218201?
This trial is currently completed. It is a NA study. The enrollment target is 321 participants. The study started on 2020-03-25. Estimated completion is 2024-05-17.
What interventions are being tested in trial NCT04218201?
The interventions under investigation include: PCP brief advice (BEHAVIORAL), Video doctor (BEHAVIORAL), Telephone health coaching (BEHAVIORAL), Nurse Care Manager (NCM) intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04218201?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.